Interleukin‐37 promotes DMBA/TPA skin cancer through SIGIRR‐mediated inhibition of glycolysis in CD103(+)DC cells

Interleukin 37 (IL‐37), a member of the IL‐1 family, is considered a suppressor of innate and adaptive immunity and, hence is a regulator of tumor immunity. However, the specific molecular mechanism and role of IL‐37 in skin cancer remain unclear. Here, we report that IL‐37b‐transgenic mice (IL‐37tg...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Fan‐lian, Wang, Xiao‐yan, Hu, Ya‐wen, Wang, Zhen, Li, Ya, Hu, Jing, Yu, Jia‐dong, Zhou, Pei, Teng, Xiu, Zhou, Hong, Zheng, Hua‐ping, Zhao, Fu‐lei, Gu, Lin‐na, Yue, Cheng‐cheng, Chen, Shu‐wen, Cheng, Juan, Hao, Yan, Zhao, Qi‐xiang, Zhang, Chen, Zou, Song, Hu, Zhong‐lan, Wei, Xiao‐qiong, Liu, Xiao, Li, Guo‐lin, Huang, Nong‐yu, Wu, Wen‐ling, Zhou, Yi‐fan, Li, Wei, Cui, Kaijun, Li, Jiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986080/
https://www.ncbi.nlm.nih.gov/pubmed/36891351
http://dx.doi.org/10.1002/mco2.229

Ejemplares similares

Ejemplares similares